Close Menu

NEW YORK (360Dx) — French diagnostic and theranostics firm Theradiag said on Tuesday that it has received CE marking for its Lisa Tracker drug response kit for Novartis' Cosentyx (secukinumab), a treatment for psoriasis, psoriatic arthritis, and ankylosing spondylitis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.